News
fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):228-236. About Hyphens Pharma Internationa ...
Hosted on MSN24d
Endo, Inc. Partners with MC2 Therapeutics to Bring Wynzora® Cream to Canadian MarketMALVERN, PA — Endo, Inc. (OTCQX: NDOI) has reached a definitive agreement with MC2 Therapeutics to commercialize Wynzora® Cream in Canada through its subsidiary, Paladin Pharma Inc. This ...
Pharmaceutical and consumer healthcare group ... According to Hyphens, Wynzora is a cream-based fixed dose combination of calcipotriene and betamethasone dipropionate that has demonstrated high ...
announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora ® Cream (calcipotriene and betamethasone dipropionate) in Canada through ...
fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):228-236. About Hyphens Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback